PE000240
Jump to navigation
Jump to search
| Name | R.WVLTAAHCLLYPPWDKN[H5N4S2]FTENDLLVR.I |
|---|---|
| Sequence | WVLTAAHCLLYPPWDKNFTENDLLVR |
| Glycans(s) | H5N4S2 (N17) |
| Mod(s) | 57.021 (C8) |
| Molecular Weight | 5393.384 |
| Norm. RT | 122.069 |
| Protein | F2 (P00734) |
Samples
DDA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Transitions | |
|---|---|---|---|---|---|---|---|---|
| TG005104 | 61.831 | 61.450 | 122.069 | 1,344.854 | 4 | Orbitrap | Human Serum | 9 |
| TG005107 | 61.831 | 61.411 | 121.964 | 1,076.085 | 5 | Orbitrap | Human Serum | 10 |
| TG001013 | 61.363 | 61.454 | 125.052 | 1,344.854 | 4 | Orbitrap | Human Serum | 9 |
DIA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Intensity | |
|---|---|---|---|---|---|---|---|---|
| TG008186 | 47.633 | 47.633 | 131.164 | 1,344.854 | 4 | TripleTOF | Human Serum | 195,868 |
| TG008095 | 47.640 | 47.640 | 131.194 | 1,076.085 | 5 | TripleTOF | Human Serum | 187,988 |
| TG008698 | 48.865 | 48.865 | 142.187 | 1,076.085 | 5 | TripleTOF | Human Serum | 165,422 |
| TG008999 | 47.684 | 47.684 | 137.964 | 1,076.085 | 5 | TripleTOF | Human Serum | 157,216 |
| TG008395 | 48.749 | 48.749 | 144.349 | 1,076.085 | 5 | TripleTOF | Human Serum | 145,960 |
| TG009652 | 47.239 | 47.239 | 136.120 | 1,076.085 | 5 | TripleTOF | Human Serum | 100,968 |
| TG009316 | 49.229 | 49.229 | 142.320 | 1,076.085 | 5 | TripleTOF | Human Serum | 93,668.1 |
| TG010089 | 47.454 | 47.454 | 134.241 | 1,076.085 | 5 | TripleTOF | Human Serum | 88,583.4 |
| TG010512 | 48.597 | 48.597 | 139.248 | 1,076.085 | 5 | TripleTOF | Human Serum | 83,842.4 |
| TG009774 | 47.228 | 47.228 | 136.067 | 1,344.854 | 4 | TripleTOF | Human Serum | 65,919.4 |
| TG006566 | 43.029 | 43.029 | 118.493 | 1,076.085 | 5 | TripleTOF | Human Serum | 193.449 |